Results 111 to 120 of about 10,900 (261)

Public health responses to influenza in care homes: a questionnaire-based study of local Health Protection Units.

, 2007
BACKGROUND: Influenza virus infection poses a major threat to the elderly people in residential care. We sought to describe the extent to which local public health services in England were positioned to detect and respond effectively to influenza-like ...
Bailey, L, Cooke, M, Gupta, RK, Harling, R, Nguyen-Van-Tam, JS, Regan, M, Zhao, H   +6 more
core   +1 more source

Comparison of Model‐Predicted and Observed Evinacumab Pharmacokinetics and Efficacy in Children Aged < 5 Years With Homozygous Familial Hypercholesterolemia

CPT: Pharmacometrics &Systems Pharmacology, Volume 14, Issue 11, Page 1835-1847, November 2025.
ABSTRACT Evinacumab, an angiopoietin‐like 3 inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C) in patients with homozygous familial hypercholesterolemia (HoFH). Herein, we report pharmacokinetic and efficacy analyses of evinacumab in < 5‐year‐old patients with HoFH.
Sébastien Bihorel, Robert Dingman, Jeanne Mendell, Katy C. Norman, Richard T. George, Xue‐Qiao Zhao, Robert Pordy, Daniel Garcia, Wendy S. Putnam, Geetha Raghuveer, Brian W. McCrindle, Elena Fornari, Ivo Baric, Shubha Srinivasan, Melissa Diamond, Eliot A. Brinton, John D. Davis, A. Thomas DiCioccio, Lutz Harnisch   +18 more
wiley   +1 more source

Respiratory syncytial virus prophylaxis in preterm infants: a cost-effectiveness study from Turkey

The Turkish Journal of Pediatrics, 2012
The main aim of this study was to evaluate the cost-effectiveness of respiratory syncytial virus (RSV) prophylaxis with palivizumab in Turkey, by comparing hospitalization rates and costs as well as results of risk analyses in preterm infants who ...
Mehmet Yekta Oncel, Banu Mutlu, Sumru Kavurt, Ahmet Yağmur Baş, Nihal Demirel, Mesut Akyol, Omer Erdeve, Uğur Dilmen   +7 more
doaj  

Bronchopulmonary dysplasia [PDF]

, 2005
OBJECTIVE: To present a wide-ranging review of the literature on bronchopulmonary dysplasia, covering new definitions, pathophysiology, prevention, treatment, prognosis and progression. SOURCES OF DATA: The most relevant articles published on the subject
Miyoshi, Milton Harumi, Monte, Luciana F. Velloso, Rozov, Tatiana, Silva Filho, Luiz Vicente F. Da   +3 more
core   +3 more sources

Comparative Effectiveness of Monoclonal Antibody Prophylaxis for Preventing Severe Respiratory Syncytial Virus Infection in Infants: A Network Meta-Analysis

Journal of Clinical Question
Introduction: Respiratory syncytial virus (RSV) is a leading cause of LRTI and hospitalization in infants and young children. Passive immunization with monoclonal antibodies represents a major strategy for RSV prevention.
Tetsuya Nosho, Yukiho Otsu, Miri Nomura, Yumeng Zhang   +3 more
doaj   +1 more source

The clinical significance of palivi-zumab in the prevention of severe respiratory infections in newborn infants [PDF]

Саратовский научно-медицинский журнал, 2016
Palivizumab is known as the world's first drug with proven efficacy for passive immunization of severe infections of lower respiratory tract in preterm infants.
Bykova Е.М., Gavrilova E.S., Borisova А.А., Pazgalyova N.V., Panina O.S., Chernenkov Yu.V.   +5 more
doaj  

A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation

BMC Research Notes, 2012
Background Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections (LRTIs) in children globally. Predisposing conditions for the development of serious RSV disease include preterm infants and those with cardiopulmonary ...
Turti Tatyana V, Baibarina Elena N, Degtiareva Elena A, Keshishyan Elena S, Lobzin Yurii V, Namazova-Вaranova Leyla S, Prodeus Andrey P, Gudkov Konstantin M, Kruglova Anna I, Schulz Gregory A, Notario Gerard F   +10 more
doaj   +1 more source

Bronchiolitis caused by respiratory syncytial virus in the period from 2003 to 2009 [PDF]

, 2009
Respiratorni sincicijski virus (RSV) uzrokuje akutne respiratorne infekcije u osoba svih dobnih skupina. Donji dišni putovi češće su zahvaćeni u dojenčadi i male djece s primoinfekcijom te u starijih i imunokompromitiranih, dok su u ostalih obično ...
Branko Miše, Goran Tešović, Ivica Knezović, Leo Markovinović, Srđan Roglić   +4 more
core   +1 more source

Genetically engineered parasites: the solution to designing an effective malaria vaccine?

, 2010
Genetic engineering provides an ingenious method of attenuating Plasmodium falciparum parasites for next generation vaccines.
Cooke, Mary K, Fitchett, Joseph R
core   +1 more source

Respiratory syncytial virus: diagnosis, prevention and management. [PDF]

, 2019
Respiratory syncytial virus (RSV) is responsible for a large burden of disease globally and can present as a variety of clinical syndromes in children of all ages.
British Thoracic Society, Drysdale SB, Farley R, Fernandes RM, Gadomski AM, Gebretsadik T, Hartling L, Liu F, Public Health England. Chapter 27a: Respiratory Syncytial Virus, Roberto PS, Roqué i Figuls M, Smith C, Teale A, Wang D, Zhang L   +14 more
core   +1 more source